Drug Profile
L 791515
Alternative Names: MK-0703Latest Information Update: 18 Mar 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Analgesics; Anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 02 Mar 2005 Phase-II trials in Pain in USA (unspecified route)